prof. dr. M.J. (Maarten) Postma

Professor Global Health Economics UMCG & RUG

prof. dr. M.J. (Maarten) Postma
Telephone:
E-mail:
m.j.postma rug.nl

Research

  1. 2001
  2. Postma, MJ., Los, APM., Ruitenberg, EJ., & Sibinga, CTS. (2001). Cost-effectiveness of HIVNAT screening for Dutch donors. In CTS. Sibinga, & JD. Cash (Eds.), TRANSFUSION MEDICINE: QUO VADIS? WHAT HAS BEEN ACHIEVED, WHAT IS TO BE EXPECTED (pp. 45-51). (DEVELOPMENTS IN HEMATOLOGY AND IMMUNOLOGY; Vol. 36). Springer.
  3. Postma, M., & Kuipers, EW. (2001). De kosten van HIV/Aids. Pharmaceutisch Weekblad, 136, 937-946.
  4. Postma, M., Heijnen, M-LA., & Jager, JC. (2001). Kosten-effectiviteitsanalyse van pneumokokkenvaccinatie voor Nederlandse 65+'ers. In R. van Furth (Ed.), Pneumokokkeninfecties in de 21e eeuw (pp. 71-80). (Boerhaave Cursussen).
  5. Postma, M., Rutten, WJMJ., & de Vries, C. (2001). Langs de valkuilen (8) Farmaco-economisch onderzoek. Pharmaceutisch Weekblad, 136(41), 1542-1545.
  6. Postma, M., Tolley, K., & Jager, JC. (2001). Modelling the health-care costs of drug-use-related disease: Part V: Economic Models, Chapter 12. In Modelling drug use: methods to quantify and understand hidden processes (pp. 205-220). (EMCDDA Scientific Monograph Series).
  7. de Walle, H., de Smit, DJ., Pal-de Bruin, K., Postma, M., & de Jong-van den Berg, L. (2001). Opinie: Foliumzuur en verrijking: terug bij af. Pharmaceutisch Weekblad, 136(9), 282-325.
  8. Jager, JC., Postma, M., & Achterberg , PW. (2001). Part IV: Modelling the health consequences of drug use, Chapter 11: Developing multinational scenario analysis of health impacts of drug use. In Modelling drug use: methods to quantify and understand hidden processes (pp. 183-201). (EMCDDA Scientific Monograph Series ).
  9. Godfrey, C., Parrot, S., Sutton, M., Waby, V., Young, P., Comiskey , C., Frischer , M., Hay , G., Hickman , M., Jager, J., Kahan , J., Kraus , L., Mollica, R., Postma, M., Simon , R., Taylor , C., & Wiessing, L. (2001). Part 1: What is modelling and how can it be used? In Modelling drug use: methods to quantify and understand hidden processes (Vol. chapter 2, pp. 33-52). (EMCDDA Scientific Monograph Series ).
  10. Postma, M., Smit Sibinga, C. T., & Ruitenberg, EJ. (2001). Pharmaco-economics of transfusion safety. In CT. Smit Sibinga, & JD. Cash (Eds.), Quo Vadis (pp. 45-51). Kluwer.
  11. 2000
  12. Postma, M. J., Bakker, A., Welte, R., Van Bergen, J. E. A. M., Van den Hoek, J. A. R., De Jong-Van den Berg, L. T. W., & Jager, J. C. (2000). Screening op Asymptomatische Chlamydia. Nederlands Tijdschrift voor Geneeskunde, 144(49), 2350-2354.
  13. Postma, MJ., Beck, EJ., Hankins, CA., Mandalia, S., Jager, JC., de Jong-van den Berg, LTW., & Sherr, L. (2000). Cost effectiveness of expanded antenatal HIV testing in London. Aids, 14(15), 2383-2389.
  14. Postma, MJ., Baltussen, RMPM., Heijnen, MLA., de Jong-van den Berg, LTW., & Jager, JC. (2000). Pharmacoeconomics of influenza vaccination in the elderly - Reviewing the available evidence. Drugs & Aging, 17(3), 217-227.
  15. Postma, M., Welte, R., van den Hoek, A., van Doornum, G., Mulder-Folkerts, D., Couthino, RA., & Jager, JC. (2000). Cost-effectiveness of screening asymptomatic women for Chlamydia trachomatis: The importance of reinfection and partner referral. Value in Health, 4(3), 266-275.
  16. Struijs, JN., Wit, GAD., Kretzschmar, M. E. E., Smits , LJM., Postma, M., van der Laar, MWJ., & Jager, JC. (2000). Kosten en effecten van algemene vaccinatie tegen hepatitis. Infectieziekten Bulletin, 11(7), 109-144.
  17. 1999
  18. Postma, M. J., Welte, R., Van Den Hoek, J. A. R., Jager, J. C., Van Doornum, G. J. J., & Coutinho, R. A. (1999). Opportunistische Screening op Chlamydia. Nederlands Tijdschrift voor Geneeskunde, 143(47), 2383-2385.
  19. Rutten-van Mölken, M. P., Postma, M., Joore, M. A., Van Genugten, M. L., Leidl, R., & Jager, J. C. (1999). Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands. Respiratory Medicine, 93(11), 779 - 787.
  20. Postma, M., Beck, E. J., Mandalia, S., Sherr, L., Walters, M. D., Houweling, H., & Jager, J. C. (1999). Universal HIV screening of pregnant women in England: cost effectiveness analysis. BMJ Magazine, 318(7199), 1656-1660. https://doi.org/10.1136/bmj.318.7199.1656
  21. Postma, M. J., Bos, J. M., Van Gennep, M., Jager, J. C., Baltussen, R., & Sprenger, M. J. W. (1999). Economic evaluation of influenza vaccination: Assessment for The Netherlands. Pharmacoeconomics, 16(SUPPL. 1), 33-40. https://doi.org/10.2165/00019053-199916001-00005
  22. 1997
  23. Postma, M., Tolley, K., Leidl, R. M., Downs, A. M., Beck, E. J., Tramarin, A. M., Flori, Y. A., Santin, M., Antoñanzas, F., Kornarou, H., Paparizos, V. C., Dijkgraaf, M. G., Borleffs, J., Luijben, A. J., & Jager, J. C. (1997). Hospital care for persons with AIDS in the European Union. Health Policy, 41(2), 157-76. https://doi.org/10.1016/S0168-8510(97)00019-5
  24. 1995
Previous 1...11 12 13 14 15 Next

ID: 193217